DISCLOSURE POLICY AND CONFLICT OF INTEREST STATEMENT

Participants in NASCE 2011 are required to disclose any relevant financial relationship(s) that have occurred within the last 12 months with any commercial interest(s) who provided financial support for the research and/or whose products or services are discussed in the presentation. Such relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent participants with relevant financial relationships from planning or delivery of content, but rather to provide attendees with information that allows them to make their own judgments. It remains for attendees to determine whether financial interests or relationships may influence the educational activity with regard to exposition or conclusion. The NASCE 2011 Program and Scientific Advisory Committees will review all disclosures and inform presenters of the need to mention the potential conflict of interest at the time of their presentation. Presenter disclosures will be published in the NASCE 2011 program.

The corresponding author confirms that commercial supporters have no influence over the content of the presentation.


(Adapted from the Endocrine Society disclosure statement).